B02.23

Clinical Causes: Reactivation of the varicella-zoster virus in nerve tissues following primary chickenpox infection Age-related decline in immune system effectiveness, increasing risk among older adults Severeness and extent of the initial shingles outbreak Inadequate immune response or immune suppression conditions

Key Symptoms: Persistent burning, stabbing, or aching pain in areas previously affected by shingles Numbness or tingling sensations in the affected regions Heightened sensitivity to touch, often causing pain from light contact Muscle weakness or loss of coordination in some cases Sharp or shooting pains that can occur intermittently or continuously Often manifests in the dermatomal distribution, corresponding to the nerve where the shingles occurred

Diagnosis Path: Diagnosis typically involves a clinical assessment by a healthcare provider familiar with nerve pain conditions. The provider will review the patient’s history of shingles and current symptoms. No specific laboratory test confirms postherpetic polyneuropathy universally, but tests such as nerve conduction studies or electromyography (EMG) may be used to evaluate nerve function. In some cases, ruling out other causes of neuropathy, such as diabetes or other systemic illnesses, is necessary to confirm the diagnosis.

Treatment Protocols: Medications such as anticonvulsants (e.g., gabapentin, pregabalin), antidepressants (e.g., amitriptyline), and topical agents like lidocaine patches or capsaicin Pain management strategies tailored to individual needs Physical therapy to maintain muscle strength and function Psychological support or counseling if chronic pain leads to emotional distress In some cases, nerve blocks or other interventional procedures may be considered